サマリー

制吐剤の世界市場 2023-2027
制吐剤市場は2022-2027年に16億3,281万米ドルで成長し、予測期間中のCAGRは6.47%で加速すると予測される。当レポートでは、制吐剤市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、世界的な老人人口の増加、吐き気・嘔吐の有病率の増加、医療費の増加によって牽引されています。
Technavio社の制吐剤市場は以下のようにセグメント化されています：
用途別
- 化学療法
- 外科療法
- 胃腸炎
- その他
薬剤クラス別
- 5-ヒドロキシトリプタミン3（5-HT 3）受容体拮抗薬
- ドーパミン拮抗薬
- ニューロキニン-1（NK 1）受容体拮抗薬
- カンナビノイド受容体拮抗薬
- その他
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、制吐剤管理におけるデジタルヘルスソリューションの統合が、今後数年間の制吐剤市場の成長を促進する主要な理由の1つであると特定している。また、制吐薬に関連する最近の開発件数の増加や新興国における制吐薬の需要の高まりは、市場の大きな需要につながるでしょう。
本レポートでは、制吐薬市場について以下の領域をカバーしています：
- 制吐剤市場のサイジング
- 制吐剤市場の予測
- 制吐剤市場の産業分析
本レポートでは、制吐剤市場の主要ベンダーであるAlgen Healthcare Ltd.、Boehringer Ingelheim International GmbH、Bristol Laboratories Ltd.、Cadila Pharmaceuticals Ltd.、Cipla Ltd.、Eagle Pharmaceuticals Inc.、Fresenius SE and Co.KGaA、GlaxoSmithKline Plc、Helsinn Healthcare SA、Heron Therapeutics Inc.、Lupin Ltd.、Merck and Co.Inc.、ノバルティスAG、大塚ホールディングスInc.武田薬品工業株式会社、Teva Pharmaceutical Industries Ltd.、Helsinn Healthcare SA、Heron Therapeutics Inc.、Lupin Ltd.、Merck and Co.Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc.などである。また、制吐薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/antiemetic-drug-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global antiemetic drug market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global antiemetic drug market 2017 - 2021 ($ million)
o 4.2 Drug Class Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Drug Class Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 30: Chart on Drug Class - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Drug Class - Market share 2022-2027 (%)
o 6.2 Comparison by Drug Class
o Exhibit 32: Chart on Comparison by Drug Class
o Exhibit 33: Data Table on Comparison by Drug Class
o 6.3 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2022-2027
o Exhibit 34: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2022-2027 (%)
o 6.4 Dopamine antagonist - Market size and forecast 2022-2027
o Exhibit 38: Chart on Dopamine antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Dopamine antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Dopamine antagonist - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Dopamine antagonist - Year-over-year growth 2022-2027 (%)
o 6.5 Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2022-2027
o Exhibit 42: Chart on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2022-2027 (%)
o 6.6 Cannabinoid receptor antagonist - Market size and forecast 2022-2027
o Exhibit 46: Chart on Cannabinoid receptor antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Cannabinoid receptor antagonist - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Cannabinoid receptor antagonist - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Drug Class
o Exhibit 54: Market opportunity by Drug Class ($ million)
o Exhibit 55: Data Table on Market opportunity by Drug Class ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 56: Chart on Application - Market share 2022-2027 (%)
o Exhibit 57: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 58: Chart on Comparison by Application
o Exhibit 59: Data Table on Comparison by Application
o 7.3 Chemotherapy - Market size and forecast 2022-2027
o Exhibit 60: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
o 7.4 Surgery - Market size and forecast 2022-2027
o Exhibit 64: Chart on Surgery - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Surgery - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Surgery - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Surgery - Year-over-year growth 2022-2027 (%)
o 7.5 Gastroenteritis - Market size and forecast 2022-2027
o Exhibit 68: Chart on Gastroenteritis - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Data Table on Gastroenteritis - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Chart on Gastroenteritis - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Gastroenteritis - Year-over-year growth 2022-2027 (%)
o 7.6 Others - Market size and forecast 2022-2027
o Exhibit 72: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 76: Market opportunity by Application ($ million)
o Exhibit 77: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 81: Chart on Geographic comparison
o Exhibit 82: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 113: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 119: Market opportunity By Geographical Landscape ($ million)
o Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 121: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 123: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 124: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 125: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 126: Matrix on vendor position and classification
o 12.3 Boehringer Ingelheim International GmbH
o Exhibit 127: Boehringer Ingelheim International GmbH - Overview
o Exhibit 128: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 129: Boehringer Ingelheim International GmbH - Key news
o Exhibit 130: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 131: Boehringer Ingelheim International GmbH - Segment focus
o 12.4 Cadila Pharmaceuticals Ltd.
o Exhibit 132: Cadila Pharmaceuticals Ltd. - Overview
o Exhibit 133: Cadila Pharmaceuticals Ltd. - Product / Service
o Exhibit 134: Cadila Pharmaceuticals Ltd. - Key offerings
o 12.5 Cipla Ltd.
o Exhibit 135: Cipla Ltd. - Overview
o Exhibit 136: Cipla Ltd. - Business segments
o Exhibit 137: Cipla Ltd. - Key news
o Exhibit 138: Cipla Ltd. - Key offerings
o Exhibit 139: Cipla Ltd. - Segment focus
o 12.6 Fresenius SE and Co. KGaA
o Exhibit 140: Fresenius SE and Co. KGaA - Overview
o Exhibit 141: Fresenius SE and Co. KGaA - Business segments
o Exhibit 142: Fresenius SE and Co. KGaA - Key news
o Exhibit 143: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 144: Fresenius SE and Co. KGaA - Segment focus
o 12.7 GlaxoSmithKline Plc
o Exhibit 145: GlaxoSmithKline Plc - Overview
o Exhibit 146: GlaxoSmithKline Plc - Business segments
o Exhibit 147: GlaxoSmithKline Plc - Key news
o Exhibit 148: GlaxoSmithKline Plc - Key offerings
o Exhibit 149: GlaxoSmithKline Plc - Segment focus
o 12.8 Helsinn Healthcare SA
o Exhibit 150: Helsinn Healthcare SA - Overview
o Exhibit 151: Helsinn Healthcare SA - Product / Service
o Exhibit 152: Helsinn Healthcare SA - Key offerings
o 12.9 Lupin Ltd.
o Exhibit 153: Lupin Ltd. - Overview
o Exhibit 154: Lupin Ltd. - Product / Service
o Exhibit 155: Lupin Ltd. - Key news
o Exhibit 156: Lupin Ltd. - Key offerings
o 12.10 Merck and Co. Inc.
o Exhibit 157: Merck and Co. Inc. - Overview
o Exhibit 158: Merck and Co. Inc. - Business segments
o Exhibit 159: Merck and Co. Inc. - Key news
o Exhibit 160: Merck and Co. Inc. - Key offerings
o Exhibit 161: Merck and Co. Inc. - Segment focus
o 12.11 Novartis AG
o Exhibit 162: Novartis AG - Overview
o Exhibit 163: Novartis AG - Business segments
o Exhibit 164: Novartis AG - Key offerings
o Exhibit 165: Novartis AG - Segment focus
o 12.12 Otsuka Holdings Co. Ltd.
o Exhibit 166: Otsuka Holdings Co. Ltd. - Overview
o Exhibit 167: Otsuka Holdings Co. Ltd. - Business segments
o Exhibit 168: Otsuka Holdings Co. Ltd. - Key offerings
o Exhibit 169: Otsuka Holdings Co. Ltd. - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 170: Pfizer Inc. - Overview
o Exhibit 171: Pfizer Inc. - Product / Service
o Exhibit 172: Pfizer Inc. - Key news
o Exhibit 173: Pfizer Inc. - Key offerings
o 12.14 Sanofi
o Exhibit 174: Sanofi - Overview
o Exhibit 175: Sanofi - Business segments
o Exhibit 176: Sanofi - Key news
o Exhibit 177: Sanofi - Key offerings
o Exhibit 178: Sanofi - Segment focus
o 12.15 Takeda Pharmaceutical Co. Ltd.
o Exhibit 179: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 180: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 181: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 182: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 183: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 184: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 185: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 186: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 187: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 188: Viatris Inc. - Overview
o Exhibit 189: Viatris Inc. - Business segments
o Exhibit 190: Viatris Inc. - Key news
o Exhibit 191: Viatris Inc. - Key offerings
o Exhibit 192: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 193: Inclusions checklist
o Exhibit 194: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 195: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 196: Research methodology
o Exhibit 197: Validation techniques employed for market sizing
o Exhibit 198: Information sources
o 13.5 List of abbreviations
o Exhibit 199: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global antiemetic drug market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Drug Class Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits31: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Drug Class
Exhibits33: Data Table on Comparison by Drug Class
Exhibits34: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on 5-Hydroxytryptamine 3 (5-HT 3) receptor antagonist - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Dopamine antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Dopamine antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Dopamine antagonist - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Dopamine antagonist - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Neurokinin-1 (NK 1) receptor antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Neurokinin-1 (NK 1) receptor antagonist - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Cannabinoid receptor antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Cannabinoid receptor antagonist - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Cannabinoid receptor antagonist - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Cannabinoid receptor antagonist - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Drug Class ($ million)
Exhibits55: Data Table on Market opportunity by Drug Class ($ million)
Exhibits56: Chart on Application - Market share 2022-2027 (%)
Exhibits57: Data Table on Application - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Application
Exhibits59: Data Table on Comparison by Application
Exhibits60: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Surgery - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Surgery - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Surgery - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Surgery - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Gastroenteritis - Market size and forecast 2022-2027 ($ million)
Exhibits69: Data Table on Gastroenteritis - Market size and forecast 2022-2027 ($ million)
Exhibits70: Chart on Gastroenteritis - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Gastroenteritis - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits73: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits74: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits76: Market opportunity by Application ($ million)
Exhibits77: Data Table on Market opportunity by Application ($ million)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits112: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits113: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits116: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ million)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Boehringer Ingelheim International GmbH - Overview
Exhibits128: Boehringer Ingelheim International GmbH - Business segments
Exhibits129: Boehringer Ingelheim International GmbH - Key news
Exhibits130: Boehringer Ingelheim International GmbH - Key offerings
Exhibits131: Boehringer Ingelheim International GmbH - Segment focus
Exhibits132: Cadila Pharmaceuticals Ltd. - Overview
Exhibits133: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits134: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits135: Cipla Ltd. - Overview
Exhibits136: Cipla Ltd. - Business segments
Exhibits137: Cipla Ltd. - Key news
Exhibits138: Cipla Ltd. - Key offerings
Exhibits139: Cipla Ltd. - Segment focus
Exhibits140: Fresenius SE and Co. KGaA - Overview
Exhibits141: Fresenius SE and Co. KGaA - Business segments
Exhibits142: Fresenius SE and Co. KGaA - Key news
Exhibits143: Fresenius SE and Co. KGaA - Key offerings
Exhibits144: Fresenius SE and Co. KGaA - Segment focus
Exhibits145: GlaxoSmithKline Plc - Overview
Exhibits146: GlaxoSmithKline Plc - Business segments
Exhibits147: GlaxoSmithKline Plc - Key news
Exhibits148: GlaxoSmithKline Plc - Key offerings
Exhibits149: GlaxoSmithKline Plc - Segment focus
Exhibits150: Helsinn Healthcare SA - Overview
Exhibits151: Helsinn Healthcare SA - Product / Service
Exhibits152: Helsinn Healthcare SA - Key offerings
Exhibits153: Lupin Ltd. - Overview
Exhibits154: Lupin Ltd. - Product / Service
Exhibits155: Lupin Ltd. - Key news
Exhibits156: Lupin Ltd. - Key offerings
Exhibits157: Merck and Co. Inc. - Overview
Exhibits158: Merck and Co. Inc. - Business segments
Exhibits159: Merck and Co. Inc. - Key news
Exhibits160: Merck and Co. Inc. - Key offerings
Exhibits161: Merck and Co. Inc. - Segment focus
Exhibits162: Novartis AG - Overview
Exhibits163: Novartis AG - Business segments
Exhibits164: Novartis AG - Key offerings
Exhibits165: Novartis AG - Segment focus
Exhibits166: Otsuka Holdings Co. Ltd. - Overview
Exhibits167: Otsuka Holdings Co. Ltd. - Business segments
Exhibits168: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits169: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits170: Pfizer Inc. - Overview
Exhibits171: Pfizer Inc. - Product / Service
Exhibits172: Pfizer Inc. - Key news
Exhibits173: Pfizer Inc. - Key offerings
Exhibits174: Sanofi - Overview
Exhibits175: Sanofi - Business segments
Exhibits176: Sanofi - Key news
Exhibits177: Sanofi - Key offerings
Exhibits178: Sanofi - Segment focus
Exhibits179: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits180: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits181: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits182: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits183: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits184: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits185: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits186: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits187: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits188: Viatris Inc. - Overview
Exhibits189: Viatris Inc. - Business segments
Exhibits190: Viatris Inc. - Key news
Exhibits191: Viatris Inc. - Key offerings
Exhibits192: Viatris Inc. - Segment focus
Exhibits193: Inclusions checklist
Exhibits194: Exclusions checklist
Exhibits195: Currency conversion rates for US$
Exhibits196: Research methodology
Exhibits197: Validation techniques employed for market sizing
Exhibits198: Information sources
Exhibits199: List of abbreviations